ACI-24.060

Alzheimer's, cardiovascular, and other chronic diseases; biomarkers, lifestyle, supplements, drugs, and health care.
Post Reply
antimatter37
Contributor
Contributor
Posts: 56
Joined: Fri Feb 02, 2018 11:52 am

ACI-24.060

Post by antimatter37 »

Interesting phase1/2 result. AC Immune's "vaccine" ACI-24.060 has showed positive results and initial safety at low doses. The trial is now moving to higher doses. The drug is a liposome vaccine that stimulates one's own body to produce amyloid beta antibodies and subsequently clear the plaques from the body. It will be very interesting to see how this evolves and ultimately compares to the direct injection of monoclonal antibodies regarding AB clearance. Here is a link to a press release.

https://www.globenewswire.com/en/news-r ... Trial.html
Post Reply